Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 3.17 AUD -1.25% Market Closed
Market Cap: 257.6m AUD

Intrinsic Value

The intrinsic value of one MYX stock under the Base Case scenario is hidden AUD. Compared to the current market price of 3.17 AUD, Mayne Pharma Group Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

MYX Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Mayne Pharma Group Ltd

Intrinsic Value History
Dive into the past to invest in the future

MYX looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if MYX is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about MYX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MYX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Mayne Pharma Group Ltd.

Explain Valuation
Compare MYX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

A history of profit margin pressure in the generic drugs segment has undermined Mayne Pharma’s earnings stability, indicating that heightened competition could erode pricing power faster than the firm can offset with new product launches.

Bull Theses

The specialty products focus, especially in dermatology and women’s health, holds potential for stronger margins, as these niches show sustainable demand and less direct competition than commodity generics.

Show More Less
How do you feel about MYX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mayne Pharma Group Ltd

Current Assets 352.8m
Cash & Short-Term Investments 102.8m
Receivables 181.9m
Other Current Assets 68.1m
Non-Current Assets 661.8m
PP&E 58.9m
Intangibles 545.8m
Other Non-Current Assets 57.2m
Current Liabilities 261m
Accounts Payable 30.3m
Accrued Liabilities 140.4m
Other Current Liabilities 90.3m
Non-Current Liabilities 383.3m
Long-Term Debt 2.7m
Other Non-Current Liabilities 380.7m
Efficiency

Free Cash Flow Analysis
Mayne Pharma Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mayne Pharma Group Ltd

Revenue
413m AUD
Cost of Revenue
-160.8m AUD
Gross Profit
252.2m AUD
Operating Expenses
-324.1m AUD
Operating Income
-71.9m AUD
Other Expenses
-21.9m AUD
Net Income
-93.8m AUD
Fundamental Scores

MYX Profitability Score
Profitability Due Diligence

Mayne Pharma Group Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROE is Increasing
Exceptional Gross Margin
Operating Margin is Increasing
Strong 3Y Average Gross Margin
hidden
Profitability
Score

Mayne Pharma Group Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

MYX Solvency Score
Solvency Due Diligence

Mayne Pharma Group Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

Mayne Pharma Group Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MYX Price Targets Summary
Mayne Pharma Group Ltd

Wall Street analysts forecast MYX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYX is 6.22 AUD with a low forecast of 6.16 AUD and a high forecast of 6.41 AUD.

Lowest
Price Target
6.16 AUD
94% Upside
Average
Price Target
6.22 AUD
96% Upside
Highest
Price Target
6.41 AUD
102% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MYX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MYX stock?

The intrinsic value of one MYX stock under the Base Case scenario is hidden AUD.

Is MYX stock undervalued or overvalued?

Compared to the current market price of 3.17 AUD, Mayne Pharma Group Ltd is hidden .

Back to Top